Effective Prevention and Treatment of Acute Leukemias in Mice by Activation of Thermogenic Adipose Tissues
Authors:
Open Access
- 25 July 2024
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 11 (38) , e2402332
Abstract
Acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) are common hematological malignancies in adults. Despite considerable research advances, the development of standard therapies, supportive care, and prognosis for the majority of AML and ALL patients remains poor and the development of new effective therapy is urgently needed. Here, it is reported that activation of thermogenic adipose tissues (TATs) by cold exposure or β3‐adrenergic receptor agonists markedly alleviated the development and progression of AML and ALL in mouse leukemia models. TAT activation (TATA) monotherapy substantially reduces leukemic cells in bone marrow and peripheral blood, and suppresses leukemic cell invasion, including hepatomegaly and splenomegaly. Notably, TATA therapy prolongs the survivals of AML‐ and ALL‐bearing mice. Surgical removal of thermogenic brown adipose tissue (BAT) or genetic deletion of uncoupling protein 1 (UCP1) largely abolishes the TATA‐mediated anti‐leukemia effects. Metabolomic pathway analysis demonstrates that glycolytic metabolism, which is essential for anabolic leukemic cell growth, is severely impaired in TATA‐treated leukemic cells. Moreover, a combination of TATA therapy with chemotherapy produces enhanced anti‐leukemic effects and reduces chemotoxicity. These data provide a new TATA‐based therapeutic paradigm for the effective treatment of AML, ALL, and likely other types of hematological malignancies.Keywords
Funding Information
- Vetenskapsrådet (2019‐01502, 2020–06121, 2021–06122)
- National Key Research and Development Program of China (2020YFC0846600)
- Swedish Cancer Foundation (200734PjF)
- Key Technologies Research and Development Program (2020YFC0846600)
This publication has 52 references indexed in Scilit:
- Acute myeloid leukemia: 2023 update on diagnosis, risk‐stratification, and managementAmerican Journal of Hematology, 2023
- The impact of VEGF on cancer metastasis and systemic diseaseSeminars in Cancer Biology, 2022
- Subversion of Systemic Glucose Metabolism as a Mechanism to Support the Growth of Leukemia CellsCancer Cell, 2018
- Genetic Depletion of Adipocyte Creatine Metabolism Inhibits Diet-Induced Thermogenesis and Drives ObesityCell Metabolism, 2017
- AMPK Protects Leukemia-Initiating Cells in Myeloid Leukemias from Metabolic Stress in the Bone MarrowCell Stem Cell, 2015
- Cell-State-Specific Metabolic Dependency in Hematopoiesis and LeukemogenesisCell, 2014
- What We Talk About When We Talk About FatCell, 2014
- Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and HumanCell, 2012
- Potential chemotherapy side effects: What do oncologists tell parents?Pediatric Blood & Cancer, 2008
- TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasmsCell, 1991